Information for ligand DM2
sdf, pdb, mol, mol2
Ligand Name: Doxorubicin
Synonyms
| 1 | (1s,3s)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside |
| 2 | (1s,3s)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside |
| 3 | 14-hydroxydaunomycin |
| 4 | 14-hydroxydaunorubicine |
| 5 | (8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione |
| 6 | Adriamycin |
| 7 | Doxorubicinum |
| 8 | Doxorubicine |
Chemical Component Summary
| Formula | "C27 H29 N O11" |
| Molecular Weight | 543.519 |
| SMILES | COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO |
| InchI | InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 |
| InChIkey | AOJJSUZBOXZQNB-TZSSRYMLSA-N |
| DrugBank Reference | DB00997 |
| ChEBI Reference | 28748 |
| PubChem Reference | 31703 |
| FDA approved drug | yes |
Reference